Ex Parte HAUER-JENSEN et al - Page 3


                 Appeal No.  2001-1030                                                         Page 3                    
                 Application No.  09/159,334                                                                             

                        Orazipone in treating radiation enteropathy having recognized that                               
                        radiation enteropathy is encompassed by the Backstrom et al.                                     
                        reference.  In particular, ‘enteropathy’ as defined in any standard                              
                        medical dictionary is any disease of the intestines and the term                                 
                        ‘bowel’ as recognized in any standard medical dictionary is defined                              
                        as the intestine.  Hence, since Backstrom teaches that Orazipone                                 
                        may be administered to treat inflammatory bowel diseases and                                     
                        does not limit to one specific inflammatory bowel condition, but                                 
                        discloses that chronic inflammatory conditions of the                                            
                        gastrointestinal tract are also encompassed by their invention                                   
                        (abstract; column 1, lines 9-23) and since Applicant’s independent                               
                        claim 1 does not include a radiation step; (1) radiation exposure is                             
                        not necessary in the treatment of radiation enteropathy which logic                              
                        is consistent with Applicant’s disclosure on page 5, lines 9-13                                  
                        wherein Orazipone may be administered prior to, during, or                                       
                        subsequent to radiation therapy; and (2) a skilled practitioner in the                           
                        art using any standard medical dictionary would recognize that                                   
                        ‘enteropathy’ and ‘bowel disease’ are interchangeable terms since                                
                        the medical dictionary discloses that both terms refer to diseases of                            
                        the intestines.                                                                                  
                 Examiner’s Answer, pages 4-5.                                                                           
                        Appellants contend that, contrary to the examiner’s assertion, that                              
                 radiation enteropathy does not fall under the umbrella of inflammatory bowel                            
                 diseases, and is thus not encompassed by the Backström reference.                                       
                 Inflammatory bowel disease, according to appellants, refers only to Crohn’s                             
                 disease and ulcerative colitis, whereas radiation enteropathy results from                              
                 exposure to radiation during cancer treatment, causing chronic intestinal toxicity                      
                 that damages the small intestine.  Appellants cite the Resbeut and Martenson                            
                 references to support their position that radiation enteropathy is distinct from the                    
                 chronic inflammatory bowel diseases encompassed by the Backström reference.                             
                        The burden is on the examiner to set forth a prima facie case of                                 
                 obviousness. See In re Fine, 837 F.2d 1071, 1074, 5 USPQ2d 1596, 1598-99                                






Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007